Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Acrivon Therapeutics, Inc. (ACRV)

NASDAQ

$1.88

$+0.04

(+2.29%)

Pre-Market

Acrivon Therapeutics, Inc. (ACRV) Live Price Chart

Last updated: ⁦2026-09-16 12:18:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Acrivon Therapeutics, Inc. (ACRV) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.88, with a market capitalisation of $83.99M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.27 to $3.56. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$83.99M
Open	$1.83
Day's High	$25.47
Day's Low	$1.05
Previous Close	$1.83
Volume	1.87K
Average Volume	383.02K
P/E Ratio	--
52-Week High	$3.56
52-Week Low	$1.27
Dividend Yield	--
Earnings Date	--

Acrivon Therapeutics, Inc. (ACRV) Pre-Market Stock Price

Acrivon Therapeutics, Inc. (ACRV) is trading at $1.88 in pre-market trading as of 2026-09-16 11:57:00, up 2.46% ($0.04) from the previous close of $1.83

Pre-market trading shows how investors are pricing ACRV before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Acrivon Therapeutics, Inc. (ACRV) 7-Day Stock Price Change

Over the past seven days, Acrivon Therapeutics, Inc. (ACRV) moved from $2.13 to $1.88, representing a decline of 11.97% ($0.25).

The stock traded between $1.81 and $2.18 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 264.64 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ACRV 52-Week Price Position

Position in Range: 26.4%

52W Low$1.27

52W High$3.56

ACRV is currently trading at $1.88, placing it 26.4% of the way from its 52-week low of $1.27 to its 52-week high of $3.56. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Acrivon Therapeutics, Inc. (ACRV)?

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.

Acrivon Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	76
Exchange	NASDAQ
Company Website	https://www.acrivon.com

How to Buy Acrivon Therapeutics, Inc. (ACRV) Stock on MEXC

Eligible investors can buy real shares of Acrivon Therapeutics, Inc. (ACRV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ACRV and Place Your Order

Open the RealStocks trading page and search for ACRV. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Acrivon Therapeutics, Inc. (ACRV) stock price today?

Acrivon Therapeutics, Inc. (ACRV) is currently trading at $ 1.88, up 2.46% ($0.04) from the previous close of $ 1.83. Intraday prices update in real time during regular trading hours.

2.Is ACRV stock going up or down today?

As of 2026-09-16 11:57:00, ACRV is trading at $ 1.88, up 2.46% ($0.04) from its previous close of $ 1.83. The stock has traded between $ 1.05 and $ 25.47 during today’s regular session. Past price movements do not guarantee future results.

3.What is ACRV pre-market price?

As of 2026-09-16 11:57:00, ACRV is trading at $ 1.88 in pre-market trading, up 2.46% ($0.04) from the previous close of $ 1.83. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ACRV after-hours price?

As of 2026-09-16 11:57:00, ACRV is trading at $ 1.83 in after-hours trading, down 0.27% ($0.01) from the regular-session close of $ 1.83. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ACRV stock trading now?

ACRV trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ACRV sit relative to its 52-week high and low?

Over the past 52 weeks, ACRV has traded between a low of $ 1.27 and a high of $ 3.56. At $ 1.88, the stock is positioned 26.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Acrivon Therapeutics, Inc. in?

Acrivon Therapeutics, Inc. (ACRV) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Acrivon Therapeutics, Inc.'s market capitalisation and where is it listed?

Acrivon Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 83.99M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ACRV valued in terms of P/E ratio and EPS?

ACRV trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.73. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Acrivon Therapeutics, Inc. pay a dividend?

Acrivon Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.